• 1
    Roodman GD 1999 Cell biology of the osteoclast. Exp Hematol 27:12291241.
  • 2
    Baron R, Neff L, Louvard D, Courtoy PJ 1985 Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kDa lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:22102222.
  • 3
    Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693702.
  • 4
    Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR 1992 Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:16221627.
  • 5
    Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P 1993 Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 90:44854489.
  • 6
    Missbach M, Jeschke M, Feyen J, Muller K, Glatt M, Green J, Susa M 1999 A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone 24:437449.
  • 7
    Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE 1997 Rescue of osteoclast function by transgenic expression of kinase- deficient Src in src−/− mutant mice. Genes Dev 11:28352844.
  • 8
    Violette SM, Shakespeare WC, Bartlett C, Guan W, Smith JA, Rickles RJ, Bohacek RS, Holt DA, Baron R, Sawyer TK 2000 A Src SH2 selective binding compound inhibits osteoclast-mediated resorption Chem Biol 7:225235.
  • 9
    Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K 2000 Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141:21292138.
  • 10
    Furuyama N, Fujisawa Y 2000 Regulation of collagenolytic protease secretion through c-Src in osteoclasts. Biochem Biophys Res Commun 272:116124.
  • 11
    Abu-Amer Y, Teitelbaum SL, Chappel JC, Schlesinger P, Ross FP 1999 Expression and regulation of RAB3 proteins in osteoclasts and their precursors. J Bone Miner Res 14:18551860.
  • 12
    Collin-Osdoby P, Oursler MJ, Webber D, Osdoby P 1991 Osteoclast-specific monoclonal antibodies coupled to magnetic beads provide a rapid and efficient method of purifying avian osteoclasts. J Bone Miner Res 6:13531365.
  • 13
    Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg T 1994 Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:52275231.
  • 14
    Pederson L, Kremer M, Foged NT, Winding B, Ritchie C, Fitzpatrick LA, Oursler MJ 1997 Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness. J Bone Miner Res 12:742752.
  • 15
    Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC 1991 Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:66136617.
  • 16
    Twamley-Stein GM, Pepperkok R, Ansorge W, Courtneidge SA 1993 The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc Natl Acad Sci USA 90:76967700.
  • 17
    Roche S, Koegl M, Barone MV, Roussel MF, Courtneidge SA 1995 DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol Cell Biol 15:11021109.
  • 18
    Rayter SI, Woodrow M, Lucas SC, Cantrell DA, Downward J 1992 p21ras mediates control of IL-2 gene promoter function in T cell activation. Embo J 11:45494556.
  • 19
    Dent P, Reardon DB, Morrison DK, Sturgill TW 1995 Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Mol Cell Biol 15:41254135.
  • 20
    Oursler M, Collin-Osdoby P, Anderson F, Li L, Webber D, Osdoby P 1991 Isolation of avian osteoclasts: Improved techniques to preferentially purify viable cells. J Bone Miner Res 6:375385.
  • 21
    Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ 1995 Estrogen modulation of osteoclast lysosomal enzyme secretion. J Cell Biochem 57:271279.
  • 22
    Hofstee BHJ 1954 Direct and continuous spectrophotometric assay of phosphomonoesterases. Arch Biochem Biophys 51:139144.
  • 23
    Barrett A, Kirschke H 1981 Proteases of diverse origin and function, cathepsin B, cathepsin D, cathepsin H, and cathepsin L. Methods Enzymol 80:535561.
  • 24
    Oda A, Druker BJ, Smith M, Salzman EW 1992 Association of pp60src with Triton X-100-insoluble residue in human blood platelets requires platelet aggregation and actin polymerization. J Biol Chem 267:2007520081.
  • 25
    Fox JE, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS 1993 On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. J Biol Chem 268:2597325984.
  • 26
    Grondin P, Plantavid M, Sultan C, Breton M, Mauco G, Chap H 1991 Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem 266:1570515709.
  • 27
    Helmke S, Pfenninger KH 1995 Growth cone enrichment and cytoskeletal association of non-receptor tyrosine kinases. Cell Motil Cytoskeleton 30:194207.
  • 28
    Horvath AR, Muszbek L, Kellie S 1992 Translocation of pp60c-src to the cytoskeleton during platelet aggregation. Embo J 11:855861.
  • 29
    Okamura H, Resh MD 1994 Differential binding of pp60c-src and pp60v-src to cytoskeleton is mediated by SH2 and catalytic domains. Oncogene 9:22932303.
  • 30
    Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R 1992 Osteoclasts express high levels of pp60c-src in association with intracellular membranes. J Cell Biol 119:10031013.
  • 31
    Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK 1996 Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc Natl Acad Sci USA 93:15401544.
  • 32
    Koegl M, Courtneidge SA, Superti-Furga G 1995 Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk. Oncogene 11:23172329.
  • 33
    Erpel T, Superti-Furga G, Courtneidge SA 1995 Mutational analysis of the Src SH3 domain: The same residues of the ligand binding surface are important for intra- and intermolecular interactions. Embo J 14:963975.
  • 34
    Okada M, Howell BW, Broome MA, Cooper JA 1993 Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. J Biol Chem 268:1807018075.
  • 35
    Superti-Furga G, Courtneidge SA 1995 Structure-function relationships in Src family and related protein tyrosine kinases. Bioessays 17:321330.
  • 36
    Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G 1993 Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. Embo J 12:26252634.
  • 37
    Tatosyan Ab, Mizenina OA 2000 Kinases of the Src family: Structure and function. Biochemistry 65:4958.
  • 38
    Porter AC, Vaillancourt RR 1998 Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17:13431352.
  • 39
    Dhar A, Shukla SD 1991 Involvement of pp60c-src in platelet-activating factor-stimulated platelets. Evidence for translocation from cytosol to membrane. J Biol Chem 266:1879718801.
  • 40
    Walker F, deBlaquiere J, Burgess AW 1993 Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J Biol Chem 268:1955219558.
  • 41
    Migliaccio A, Pagano M, Auricchio F 1993 Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 8:21832191.
  • 42
    Brubaker KD, Gay CV 2000 Estrogen stimulates protein tyrosine phosphorylation and src kinase activity in avian osteoclasts. J Cell Biochem 76:206216.
  • 43
    Gay CV, Kief NL, Bekker PJ 1993 Effect of estrogen on acidification in osteoclasts. Biochem Biophys Res Commun 192:12511259.
  • 44
    Brubaker KD, Gay CV 1999 Depolarization of osteoclast plasma membrane potential by 17beta-estradiol. J Bone Miner Res 14:18611866.